Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC7N5
|
||||
| Drug Name |
2-(cyclopentylmethyl)-N-(3-methyl-1-(4-(trifluoromethoxy)phenylamino)butan-2-yl)-4-morpholino-4-oxobutanamide
|
||||
| Synonyms |
CHEMBL523661
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H38F3N3O4
|
||||
| Canonical SMILES |
CC(C)C(CNc1ccc(OC(F)(F)F)cc1)NC(=O)C(CC2CCCC2)CC(=O)N3CCOCC3
|
||||
| InChI |
InChI=1S/C26H38F3N3O4/c1-18(2)23(17-30-21-7-9-22(10-8-21)36-26(27,28)29)31-25(34)20(15-19-5-3-4-6-19)16-24(33)32-11-13-35-14-12-32/h7-10,18-20,23,30H,3-6,11-17H2,1-2H3,(H,31,34)
|
||||
| InChIKey |
SGUFQZKYBCMRLX-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.